Innovative Biomedical Product Company Looking to Raise Fund through Equity
About Business
The company is involved in indigenous research, development, and commercialization of bioactive and other specialty glass materials and ceramic products for bone and tooth repair. Their product development focuses on both standard compositions as well as patented proprietary formulations. Over the years, they have developed a range of improved materials that combine innovation with exceptional quality and highly competitive pricing.
Clientele type
Our versatile product range addresses market segments in B2C (e.g. medical professions, clinics) as well as B2B (e.g. hospitals and companies, manufacturing and selling medical/consumer products).
Our product pipeline caters to markets having a combined global market size of USD 46 billion.
Premises
Registered office in Pune.
Asking Price Includes
Equity Stake
Reason
Want to expand the production to meet high demand
More Details
India's first and (to our knowledge) only advanced smart materials company focusing on specialty bioactive glass and ceramics as a material platform for developing multiple product lines in healthcare and allied areas.
Our world-class in-house R&D expertise and well-developed partner ecosystem for R&D and manufacturing for our products and technologies.
Partners
Core tech team comprising PhDs from Europe’s top medical schools (UCL, UK and KU Leuven, Belgium) with combined 2+ decades experience, 37 papers (published and submitted), 1 patent granted (India), and 4 patents filed (international geographies).
Partnership
Strong partnerships with India's major entities in science business incubation (Venture Center), biotech public funding (BIRAC), angel investor crowdfunding (1crowd), dentistry professional membership (Indian Dental Association), and advanced ceramics manufacturing.
Upcoming Products
First products focused on dental enamel repair (trial orders completed) and bone regeneration (products slated for launch in 2021). R&D Pipeline includes products for stem cell manufacturing, soft tissue regeneration, skincare, and microbial control.
Fund Raising activity
Till date, we have raised INR 2.9 cr (USD 395,000) through grants and equity till the seed stage. We are now raising a fresh round of funding through a syndicated pre-Series A round comprising grant and equity contribution. The round has a total ticket size of INR 4 cr (approx. USD 550,000). We have already received commitments so far of INR 1.44 cr (approx. USD 191,000) through grants and equity. We are now approaching prospective investors who may be interested in participating as the lead investor or as co-investors within the current syndicate.
Keywords
Business Tags
₹10 to ₹200 Cr
Complete Investment Banking Solution in 120 Days
Seamless Fundraising/M&A transactions
Start your growth journey with our 25+ Years of Experienced Professional Team.
Contact IBGrid Team